Adult t-cell leukemia-lymphoma in the Middle East: First report of two cases from Lebanon

Abbaszadegan MR, 2003, J CLIN MICROBIOL, V41, P2593, DOI 10.1128-JCM.41.6.2593-2595.2003; AlMufti S, 1997, J ACQ IMMUN DEF SYND, V15, P88; Arif M, 1998, ANN TROP MED PARASIT, V92, P305; Bazarbachi A, 2004, LANCET ONCOL, V5, P664, DOI 10.1016-S1470-2045(04)01608-0; BLATTNER WA, 1982, INT J CANCER, V30, P257, DOI 10.1002-ijc.2910300302; Brick WG, 2002, LEUKEMIA LYMPHOMA, V43, P127, DOI 10.1080-10428190290000374; BUNN PA, 1983, NEW ENGL J MED, V309, P257, DOI 10.1056-NEJM198308043090501; CATOVSKY D, 1982, LANCET, V1, P639; CONSTANTINE NT, 1991, EPIDEMIOL INFECT, V107, P429; Fawaz NA, 2005, AM J INFECT CONTROL, V33, P189, DOI 10.1016-j.ajic.2004.08.006; FRANCHINI G, 2000, VIRAL DIS HEMATOLOGY, P409; GESSAIN A, 1996, HUMAN T CELL LYMPHOT, P33; HOLLSBERG P, 1993, NEW ENGL J MED, V328, P1173; KAPLAN JE, 1993, REV MED VIROL, V3, P137, DOI 10.1002-rmv.1980030304; Kawashti Maha I Sh, 2005, Egypt J Immunol, V12, P137; Kchour G, 2007, LEUKEMIA LYMPHOMA, V48, P330, DOI 10.1080-10428190601071717; KnoxMacaulay H, 1997, SCAND J INFECT DIS, V29, P217, DOI 10.3109-00365549709019030; LEVINE PH, 1994, INT J CANCER, V56, P177, DOI 10.1002-ijc.2910560205; MATAR G, 1996, REV MED LIBANAISE, V8, P23; MEYTES D, 1990, LANCET, V336, P1533, DOI 10.1016-0140-6736(90)93308-C; Naman R, 2002, J INFECTION, V45, P29, DOI 10.1053-jinf.2002.1006; PAUN L, 1994, EUR J HAEMATOL, V52, P117; Mufti GJ, 1998, BRIT J HAEMATOL, V100, P453; Safai BJ, 1996, AIDS RES HUM RETROV, V12, P1185, DOI 10.1089-aid.1996.12.1185; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111-j.1365-2141.1991.tb08051.x; SIDI Y, 1990, CANCER, V65, P590, DOI 10.1002-1097-0142(19900201)65:3590::AID-CNCR28206503343.0.CO;2-2; Takatsuki F, 1990, RETROVIRUS BIOL HUMA, P147; Tamim H, 2004, AM J INFECT CONTROL, V32, P220, DOI 10.1016-j.ajic.2003.10.012